Inventor · disambiguated record
David W. Andrews
Also filed as: ANDREWS DAVID · ANDREWS DAVID R · ANDREWS DAVID W · ANDREWS DAVID WAYNE
23 granted patents·13 pending applications·442 citations·filing 1995–2025
96Inventor score
Top patents by PatentIndex Score
36 records- 0194US10357509B2Methods and compositions for treating cancers using antisenseUNIV JEFFERSON·Filed 2018·Granted Jul 23, 2019·5 cites·17 claims
- 0293US6655587B2Customer administered autoloadCUBIC CORP·Filed 2002·Granted Dec 2, 2003·100 cites·18 claims
- 0391US12064446B2Methods and compositions for treating cancers and enhancing therapeutic immunity by selectively reducing immunomodulatory M2 monocytesUNIV JEFFERSON·Filed 2021·Granted Aug 20, 2024·1 cites·11 claims
- 0490US10772904B2Methods and compositions for treating cancers using antisenseUNIV JEFFERSON·Filed 2019·Granted Sep 15, 2020·2 cites·22 claims
- 0590US5807707AHigh efficiency translation of mRNA moleculesUNIV MCMASTER·Filed 1996·Granted Sep 15, 1998·122 cites·37 claims
- 0688US2025009781A1Methods and Compositions for Treating Cancers and Enhancing Therapeutic Immunity by Selectively Reducing Immunomodulatory M2 MonocytesUNIV JEFFERSON·Filed 2024·Application pending·0 cites
- 0787US11077133B2Methods and compositions for treating cancers and enhancing therapeutic immunity by selectively reducing immunomodulatory M2 monocytesUNIV JEFFERSON·Filed 2019·Granted Aug 3, 2021·1 cites·23 claims
- 0887US5824497AHigh efficiency translation of mRNA moleculesUNIV MCMASTER·Filed 1995·Granted Oct 20, 1998·91 cites·19 claims
- 0986US10265339B2Methods and compositions for treating cancers and enhancing therapeutic immunity by selectively reducing immunomodulatory M2 monocytesUNIV JEFFERSON·Filed 2018·Granted Apr 23, 2019·3 cites·24 claims
- 1085US10206942B2Methods and compositions for treating cancers and enhancing therapeutic immunity by selectively reducing immunomodulatory M2 monocytesUNIV JEFFERSON·Filed 2016·Granted Feb 19, 2019·3 cites·24 claims
- 1185US9317976B2Fare collection using wireless beaconsCUBIC CORP·Filed 2014·Granted Apr 19, 2016·17 cites·20 claims
- 1285US2024100078A1Methods and compositions for treating cancers using antisenseUNIV JEFFERSON·Filed 2023·Application pending·0 cites
- 1380US7124118B2Transit best fare system and methodCUBIC CORP·Filed 2002·Granted Oct 17, 2006·15 cites·21 claims
- 1479US10543226B2Methods and compositions for treating cancers and enhancing therapeutic immunity by selectively reducing immunomodulatory M2 monocytesUNIV JEFFERSON·Filed 2018·Granted Jan 28, 2020·1 cites·39 claims
- 1575US11801259B2Methods and compositions for treating cancers using antisenseUNIV JEFFERSON·Filed 2020·Granted Oct 31, 2023·0 cites·9 claims
- 1672US7587332B2Directed autoload of contactless stored value card within a transportation systemCUBIC CORP·Filed 2005·Granted Sep 8, 2009·5 cites·25 claims
- 1768US12472199B2P-ethoxy nucleic acids for IGF-1R inhibitionBIO PATH HOLDINGS INC·Filed 2021·Granted Nov 18, 2025·0 cites·4 claims
- 1866US6541036B1Treatment of tumors with oligonucleotides directed to insulin-like growth factor-I receptors (IGF-IR)UNIV JEFFERSON·Filed 1999·Granted Apr 1, 2003·21 cites·15 claims
- 1966US2025276166A1Biodiffusion chamberLAURENZI BRENDAN·Filed 2025·Application pending·0 cites
- 2065US7108176B2Customer administered autoloadCUBIC CORP·Filed 2003·Granted Sep 19, 2006·5 cites·19 claims
- 2164US2025179299A1Dyes for monitoring cell statesSUNNYBROOK RES INST·Filed 2023·Application pending·0 cites
- 2263US8204828B1System and method for electronic distribution of benefitsKUITE ROGER H·Filed 2000·Granted Jun 19, 2012·16 cites·25 claims
- 2357US2020038429A1P-ethoxy nucleic acids for igf-1r inhibitionBIO PATH HOLDINGS INC·Filed 2018·Application pending·0 cites
- 2456US2021052875A1Biodiffusion chamberLAURENZI BRENDAN·Filed 2019·Application pending·0 cites
- 2551US12104746B2Deployable structures, methods including the same and systems including the sameUNIV BRIGHAM YOUNG·Filed 2022·Granted Oct 1, 2024·0 cites·23 claims
- 2651US2022000916A1Methods and compositions for treating breast cancer using antisenseUNIV JEFFERSON·Filed 2019·Application pending·0 cites
- 2751US2021403918A1Methods and compositions for treating hepatocellular carcinoma using antisenseUNIV JEFFERSON·Filed 2019·Application pending·0 cites
- 2851US2022195440A1Methods for treating cancers using antisenseUNIV JEFFERSON·Filed 2020·Application pending·0 cites
- 2949US2011208645A1Virtual fare card and virtual fare deviceCUBIC CORP·Filed 2010·Application pending·0 cites
- 3047US2011165836A1Id application for nfc phoneCUBIC CORP·Filed 2010·Application pending·0 cites
- 3143US2020054761A1Methods and composition for inhibiting tumor growth and enhancing immune responses to tumorsUNIV JEFFERSON·Filed 2018·Application pending·0 cites
- 3241US2007056374A1Monitoring systemANDREWS DAVID R·Filed 2006·Application pending·0 cites
- 3337US6156538AHeterologous gene expression with poliovirus repliconFiled 1998·Granted Dec 5, 2000·2 cites·17 claims
- 3436US5810760ACerebral edema solute catheter and method of draining cerebral edemaUNIV JEFFERSON·Filed 1996·Granted Sep 22, 1998·18 cites·13 claims
- 3534US6096019ACerebral edema solute catheter and method of draining cerebral edemaUNIV JEFFERSON·Filed 1998·Granted Aug 1, 2000·14 cites·14 claims
- 3623USD1107915SBiodiffusion chamberUNIV JEFFERSON·Filed 2019·Granted Dec 30, 2025·0 cites·1 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →